sumatriptan has been researched along with Cardiovascular Diseases in 11 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In AT1, which was previously published in part, group differences in adverse events (AEs) were analyzed using the Fisher exact test, and response rates were compared using logistic regression." | 2.46 | Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies. ( Campbell, JC; Hu, X; MacGregor, EA; Pawsey, SP, 2010) |
| "Sumatriptan has been instrumental in defining a biological basis for migraine." | 2.43 | Sumatriptan: update and review. ( Cady, R; Schreiber, C, 2006) |
| "About every second (53%) migraineur using subcutaneous sumatriptan reports headache recurrence." | 2.39 | Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache. ( Dahlöf, C; Ekbom, K; Persson, L, 1994) |
| "Triptans are widely used to treat migraine but have been associated with stroke, myocardial infarction (MI), and ischemic heart disease (IHD) in case reports." | 1.32 | Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. ( Brown, MM; Hall, GC; MacRae, KD; Mo, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacGregor, EA | 1 |
| Pawsey, SP | 1 |
| Campbell, JC | 1 |
| Hu, X | 1 |
| Adelman, JU | 1 |
| Lewit, EJ | 1 |
| Hall, GC | 1 |
| Brown, MM | 1 |
| Mo, J | 1 |
| MacRae, KD | 1 |
| Dodick, DW | 1 |
| Papademetriou, V | 1 |
| Cady, R | 1 |
| Schreiber, C | 1 |
| Dahlöf, C | 1 |
| Ekbom, K | 1 |
| Persson, L | 1 |
| Gaist, D | 1 |
| Grundemar, L | 1 |
| Ottervanger, JP | 1 |
| van Witsen, TB | 1 |
| Valkenburg, HA | 1 |
| Stricker, BH | 1 |
| O'Quinn, S | 1 |
| Davis, RL | 1 |
| Gutterman, DL | 1 |
| Pait, GD | 1 |
| Fox, AW | 1 |
| Welch, KM | 1 |
| Mathew, NT | 1 |
| Stone, P | 1 |
| Rosamond, W | 1 |
| Saiers, J | 1 |
| Gutterman, D | 1 |
6 reviews available for sumatriptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
Topics: Acute Disease; Carbazoles; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dose-Respon | 2010 |
Comparative aspects of triptans in treating migraine.
Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Sa | 2001 |
Sumatriptan: update and review.
Topics: Animals; Cardiovascular Diseases; Drug Interactions; Drug Tolerance; Humans; Naproxen; Sumatriptan; | 2006 |
Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache.
Topics: Cardiovascular Diseases; Central Nervous System Diseases; Cluster Headache; Humans; Injections, Subc | 1994 |
[Sumatriptan and cardiac complaints. Careful cardiac anamnesis is needed prior to treatment].
Topics: Cardiovascular Diseases; Coronary Disease; Humans; Migraine Disorders; Sumatriptan | 1994 |
Tolerability of sumatriptan: clinical trials and post-marketing experience.
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Migraine Disor | 2000 |
1 trial available for sumatriptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Cardiovascular Diseases; Cerebrovascul | 1999 |
4 other studies available for sumatriptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Cardiovascular Diseases; Cause | 2004 |
Cardiovascular safety of triptans.
Topics: Cardiovascular Diseases; Humans; Indoles; Pyrrolidines; Sumatriptan; Tryptamines | 2004 |
[Sumatriptan (Imigran) and cardiovascular side effects].
Topics: Adult; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Risk Factors; Sumatriptan | 1994 |
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Chest Pain; Female; Humans; | 1993 |